Originally published by our sister publication Infectious Disease Special Edition
By IDSE News Staff
Pivotal studies of some biomedical HIV and sexually transmitted infection (STI) prevention interventions have excluded cisgender women or demonstrated low efficacy among them, limiting their prevention options relative to other populations who experience a high incidence of HIV and STIs.
Perhaps the problem lies in the way these studies are designed, according to Jeanne Marrazzo, MD, MPH, the